Gamma-glutamyl cysteine synthetase up-regulates glutathione and multidrug resistance-associated protein in patients with chemoresistant epithelial ovarian cancer.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Clinical Cancer Research

• Publication date

  1998-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9676849
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glutathione concentration may be a useful predictor of response to second‐line chemotherapy in patients with ovarian cancer

  1998cited by this paper
• The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer.

  1997cited by this paper
• Glutathione S‐transferase‐π expression and glutathione concentration in ovarian carcinoma before and after chemotherapy

  1997cited by this paper
• Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma.

  1997cited by this paper
• Multidrug resistance protein in recurrent breast cancer.

  1997cited by this paper
• Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy.

  1997cited by this paper
• Effects of chronic ethacrynic acid exposure on glutathione conjugation and MRP expression in human colon tumor cells.

  1996cited by this paper
• Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cells.

  1996cited by this paper
• Coordinated Induction of MRP/GS-X Pump and γ-Glutamylcysteine Synthetase by Heavy Metals in Human Leukemia Cells*

  1996cited by this paper
• Molecular mechanisms of multidrug resistance in cancer chemotherapy.

  1996cited by this paper
• Multidrug resistance mediated by the multidrug resistance protein (MRP) gene.

  1996cited by this paper
• Frequent coordinated overexpression of the MRP/GS-X pump and gamma-glutamylcysteine synthetase genes in human colorectal cancers.

  1996cited by this paper
• Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma.

  1996cited by this paper
• Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump.

  1996cited by this paper
• Influence of ethacrynic acid on glutathione S-transferase pi transcript and protein half-lives in human colon cancer cells.

  1995cited by this paper
• Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.

  1995cited by this paper
• Transduction of NIH 3T3 cells with a retrovirus carrying both human MDR1 and glutathione S-transferase pi produces broad-range multidrug resistance.

  1995cited by this paper
• Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells.

  1995cited by this paper
• Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines.

  1995cited by this paper
• Gamma-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione S-conjugate export pump and cisplatin resistance.

  1995cited by this paper
• Intracellular glutathione levels regulate Fos/Jun induction and activation of glutathione S-transferase gene expression.

  1994cited by this paper
• Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia.

  1994cited by this paper
• Glutathione-mediated modulation of tetraplatin activity against sensitive and resistant tumor cells.

  1994cited by this paper
• Glutathione S-transferase expression in benign and malignant ovarian tumours.

  1993cited by this paper
• Tumor DNA ploidy and prognosis of patients with serous cystadenocarcinoma of the ovary

  1993cited by this paper
• Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents.

  1992cited by this paper
• High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.

  1992cited by this paper
• Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin.

  1991cited by this paper
• Determinants of Drug Response in a Cisplatin‐resistant Human Lung Cancer Cell Line

  1990cited by this paper
• Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance.

  1990cited by this paper
• Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance.

  1990cited by this paper
• Persistently increased expression of a 3-methylcholanthrene-inducible phenol uridine diphosphate-glucuronosyltransferase in rat hepatocyte nodules and hepatocellular carcinomas.

  1990cited by this paper
• cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Selective modification of glutathione metabolism.

  1983cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• A COLORIMETRIC MICRO-METHOD FOR THE DETERMINATION OF GLUTATHIONE.

  1965cited by this paper

• N-Acetyl Cysteine as a promising therapeutic approach in ovarian cancer: potential and perspectives

  2025cites this paper
• From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer

  2024cites this paper
• Current progress of ferroptosis study in ovarian cancer

  2022cites this paper
• Cysteine boosters the evolutionary adaptation to CoCl2 mimicked hypoxia conditions, favouring carboplatin resistance in ovarian cancer

  2018cites this paper
• Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity

  2018cites this paper
• Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.

  2018cites this paper
• Chapter 5 Implication of Clear Cell and Mucinous Histology

  2017cites this paper
• Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate–Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma

  2017cites this paper
• Targeting the Antioxidant Enzymes to Enhance the Efficacy of Chemotherapy

  2016cites this paper
• The Role Of Oxidative Stress In The Establishment Of Resistance To Cisplatin In Epithelial Ovarian Cancer Cells

  2016cites this paper
• The role of ABC transporters in ovarian cancer progression and chemoresistance.

  2015cites this paper
• Importance of ABCC1 for cancer therapy and prognosis

  2014cites this paper
• Mucinous Epithelial Ovarian Cancer

  2014cites this paper
• Subamolide A Induces Mitotic Catastrophe Accompanied by Apoptosis in Human Lung Cancer Cells

  2013cites this paper
• Implication of Clear Cell and Mucinous Histology

  2013cites this paper
• Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer

  2013cites this paper
• New Strategy for Overcoming Resistance to Chemotherapy of Ovarian Cancer

  2013cites this paper
• Clear cell carcinoma of the ovary: a review of the literature.

  2012cites this paper
• Glutathione levels in human tumors

  2012influential citation
• ABC transporter gene expression in benign and malignant ovarian tissue.

  2010cites this paper
• Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma

  2008cites this paper
• Receptor-targeted nanocarriers for tumor specific treatment and imaging

  2008cites this paper
• Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer.

  2008cites this paper
• A new chemosensitivity test using a thermo-reversible gelation polymer for recurrent gynecologic cancer patients and a preliminary study of mechanisms of anticancer drug resistance

  2008cites this paper
• Novel use of the fluorescent dye 5‐(and‐6)‐chloromethyl SNARF‐1 acetate for the measurement of intracellular glutathione in leukemic cells and primary lymphocytes

  2007cites this paper
• Galectin-3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovary

  2007cites this paper
• Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.

  2006cites this paper
• Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma.

  2006cites this paper
• Oxidative damage and counteracting mechanisms in breast carcinoma

  2005cites this paper
• Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.

  2005cites this paper
• Identification of Overexpression and Amplification of ABCF2 in Clear Cell Ovarian Adenocarcinomas by cDNA Microarray Analyses

  2005cites this paper
• Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer

  2005cites this paper
• Leptomycin B enhances CDDP‐sensitivity via nuclear accumulation of p53 protein in HPV‐positive cells

  2003cites this paper
• Chemosensitivity and p53-Bax pathway-mediated apoptosis in patients with uterine cervical cancer.

  2003cites this paper
• Copper‐transporting P‐type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: Comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP

  2002cites this paper
• Multidrug resistance gene-1 is a useful predictor of Paclitaxel-based chemotherapy for patients with ovarian cancer.

  2002cites this paper
• Overexpression of gamma-glutamylcysteine synthetase in human malignant mesothelioma.

  2002cites this paper
• Mechanisms of Cisplatin Resistance in Clear Cell Carcinoma of the Ovary

  2002cites this paper
• ATP-binding Cassette Superfamily Transporter Gene Expression in Human Primary Ovarian Carcinoma 1

  2002cites this paper
• Low Proliferation Activity May Be Associated With Chemoresistance in Clear Cell Carcinoma of the Ovary

  2002cites this paper
• Sensitivity to Anticancer Agents and Resistance Mechanisms in Clear Cell Carcinoma of the Ovary

  2002cites this paper
• Overexpression of γ-glutamylcysteine synthetase in human malignant mesothelioma

  2002cites this paper
• COPPER-TRANSPORTIN GP-TYP EADENOSIN ETRIPHOSPHATAS E(ATP7B )AS ACISPLATI NBASE DCHEMORESISTANC EMARKE RI NOVARIAN CARCINOMA :COMPARATIV EANALYSI SWIT HEXPRESSION O FMDR1 ,MRP1 ,MRP2 ,LR PAN DBCRP

  2002cites this paper
• ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma.

  2002cites this paper
• Expression of gamma-glutamyl cysteine synthetase in nonsmall cell lung carcinoma.

  2001cites this paper
• Expression of γ‐glutamyl cysteine synthetase in nonsmall cell lung carcinoma

  2001cites this paper
• Association between expression of the MRP3 gene and exposure to platinum drugs in lung cancer

  2001cites this paper
• The expression of P-glycoprotein and multidrug resistance proteins 1 and 2 (MRP1 and MRP2) in human malignant mesothelioma.

  2001cites this paper
• Cellular Efflux Pump and Interaction between Cisplatin and Paclitaxel in Ovarian Cancer Cells

  2000cites this paper
• Microregional heterogeneity of non-protein thiols in cervical carcinomas assessed by combined use of HPLC and fluorescence image analysis.

  2000cites this paper
• Increased expression of the MRP5 gene is associated with exposure to platinum drugs in lung cancer

  2000cites this paper
• Adenovirus-mediated transfer of a p53 gene in ovarian cancer.

  2000cites this paper
• Dihydropyrimidine dehydrogenase, multidrug resistance-associated protein, and thymidylate synthase gene expression levels can predict 5-fluorouracil resistance in human gastrointestinal cancer cells.

  1999cites this paper
• Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves.

  1999cites this paper
• Gynecologic Oncology Treatment Issues in Clear Cell Carcinoma of the Ovary: a Different Entity?

  year unknowncites this paper